{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:36:27Z","timestamp":1783388187344,"version":"3.54.6"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.psc.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T10:08:30Z","timestamp":1665742110000},"page":"691-705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Psychotic Disorders in the Elderly"],"prefix":"10.1016","volume":"45","author":[{"given":"Corinne E.","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Namasivayam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Crawford-Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narek","family":"Hakobyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom A.","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psc.2022.07.001_bib1","series-title":"American Psychiatric Association. DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5","first-page":"xliv","year":"2013"},{"key":"10.1016\/j.psc.2022.07.001_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1192\/bjp.178.6.506","article-title":"Recovery from psychotic illness: a 15- and 25-year international follow-up study","volume":"178","author":"Harrison","year":"2001","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2022.07.001_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/schbul\/14.1.39","article-title":"Late-onset schizophrenia: an overview","volume":"14","author":"Harris","year":"1988","journal-title":"Schizophr Bull"},{"issue":"2","key":"10.1016\/j.psc.2022.07.001_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1176\/appi.ajp.157.2.172","article-title":"Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. the international late-onset schizophrenia group","volume":"157","author":"Howard","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2022.07.001_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00019442-199700540-00006","article-title":"Minor physical anomalies in older patients with late-onset schizophrenia, early-onset schizophrenia, depression, and Alzheimer's disease","volume":"5","author":"Lohr","year":"1997","journal-title":"Am J Geriatr Psychiatry Fall"},{"issue":"4","key":"10.1016\/j.psc.2022.07.001_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00019442-199700540-00005","article-title":"Nondementia Nonpraecox Dementia Praecox?: Late-Onset Schizophrenia","volume":"5","author":"Jeste","year":"1997","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2022.07.001_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/schbul\/19.4.691","article-title":"The epidemiology of late-onset schizophrenia","volume":"19","author":"Castle","year":"1993","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.psc.2022.07.001_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1192\/bjp.170.6.511","article-title":"A\u00a0controlled family study of late-onset non-affective psychosis (late paraphrenia)","volume":"170","author":"Howard","year":"1997","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2022.07.001_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S1041610203008767","article-title":"Case series with late-onset psychosis hospitalized in a geriatric psychiatry unit in Turkey: experience in 9 years","volume":"15","author":"Alici-Evcimen","year":"2003","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"10.1016\/j.psc.2022.07.001_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00019442-200111000-00010","article-title":"Continuation treatment of delusional depression in older adults","volume":"9","author":"Meyers","year":"2001","journal-title":"Am J Geriatr Psychiatry Fall"},{"key":"10.1016\/j.psc.2022.07.001_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.schres.2019.08.028","article-title":"Psychotic symptoms and sensory impairment: Findings from the 2014 adult psychiatric morbidity survey","volume":"215","author":"Shoham","year":"2020","journal-title":"Schizophr Res"},{"issue":"5","key":"10.1016\/j.psc.2022.07.001_bib12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.2014.14040480","article-title":"Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study","volume":"172","author":"Peters","year":"2015","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2022.07.001_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1017\/S1041610217000874","article-title":"Psychosis and dementia: risk factor, prodrome, or cause?","volume":"30","author":"Fischer","year":"2018","journal-title":"Int Psychogeriatr"},{"issue":"12","key":"10.1016\/j.psc.2022.07.001_bib14","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jagp.2020.09.002","article-title":"Criteria for psychosis in major and mild neurocognitive disorders: international psychogeriatric association (ipa) consensus clinical and research definition","volume":"28","author":"Cummings","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2022.07.001_bib15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3233\/JAD-190828","article-title":"Revisiting criteria for psychosis in alzheimer's disease and related dementias: toward better phenotypic classification and biomarker research","volume":"73","author":"Fischer","year":"2020","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.psc.2022.07.001_bib16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00019442-200307000-00003","article-title":"Psychotic symptoms in alzheimer disease: evidence for subtypes","volume":"11","author":"Cook","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2022.07.001_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1176\/appi.ajgp.12.5.449","article-title":"Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype","volume":"12","author":"Perez-Madrinan","year":"2004","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2022.07.001_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jagp.2017.10.011","article-title":"Psychosis and clinical outcomes in alzheimer disease: a longitudinal study","volume":"26","author":"Connors","year":"2018","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2022.07.001_bib19","first-page":"1","article-title":"Diagnostic criteria for dementia with lewy bodies: updates and future directions","volume":"13","author":"Yamada","year":"2020","journal-title":"J\u00a0Mov Disord"},{"issue":"6","key":"10.1016\/j.psc.2022.07.001_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1212\/WNL.0000000000007913","article-title":"Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications","volume":"93","author":"Lenka","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.psc.2022.07.001_bib21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mdc3.12806","article-title":"Spectrum of movement disorders in patients with neuroinvasive west nile virus infection","volume":"6","author":"Lenka","year":"2019","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"10.1016\/j.psc.2022.07.001_bib22","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/brain\/awaa413","article-title":"Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms","volume":"144","author":"Naasan","year":"2021","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.psc.2022.07.001_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2215-0366(19)30038-0","article-title":"A\u00a0transdiagnostic pattern of psychiatric symptoms in autoimmune encephalitis","volume":"6","author":"Finke","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"10.1016\/j.psc.2022.07.001_bib24","first-page":"e17904","article-title":"New-onset psychosis following COVID-19 infection","volume":"13","author":"Desai","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.psc.2022.07.001_bib25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/HRP.0000000000000068","article-title":"Psychosis in later life: a review and update","volume":"23","author":"Colijn","year":"2015","journal-title":"Harv Rev Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2022.07.001_bib26","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1017\/S0033291717003452","article-title":"The incidence of very late-onset psychotic disorders: a systematic review and meta-analysis, 1960-2016","volume":"48","author":"Stafford","year":"2018","journal-title":"Psychol Med"},{"issue":"2","key":"10.1016\/j.psc.2022.07.001_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-014-0542-0","article-title":"Late-life psychosis: diagnosis and treatment","volume":"17","author":"Reinhardt","year":"2015","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"10.1016\/j.psc.2022.07.001_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.14283\/jpad.2018.29","article-title":"Pimavanserin: potential treatment for dementia-related psychosis","volume":"5","author":"Cummings","year":"2018","journal-title":"J\u00a0Prev Alzheimers Dis"},{"issue":"Pt 4","key":"10.1016\/j.psc.2022.07.001_bib29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors","volume":"123","author":"F\u00e9nelon","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.psc.2022.07.001_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12519","article-title":"Mild behavioral impairment is associated with progression to Alzheimer\u2019s disease: A clinicopathological study","author":"Ruthirakuhan","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.psc.2022.07.001_bib31","doi-asserted-by":"crossref","first-page":"102188","DOI":"10.1016\/j.ajp.2020.102188","article-title":"Neuropsychiatric aspects of COVID-19 pandemic: a selective review","volume":"53","author":"Dinakaran","year":"2020","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.psc.2022.07.001_bib32","first-page":"CD004162","article-title":"Antipsychotic drug treatment for elderly people with late-onset schizophrenia","volume":"2","author":"Arunpongpaisal","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.psc.2022.07.001_bib33","first-page":"CD004162","article-title":"Antipsychotic drug treatment for elderly people with late-onset schizophrenia","volume":"2","author":"Essali","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.psc.2022.07.001_bib34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S2215-0366(18)30141-X","article-title":"Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial","volume":"5","author":"Howard","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2022.07.001_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/gps.4758","article-title":"Therapeutic D2\/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP)","volume":"33","author":"Reeves","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.psc.2022.07.001_bib36","first-page":"5","article-title":"Expert consensus panel for using antipsychotic drugs in older p. using antipsychotic agents in older patients","volume":"65","author":"Alexopoulos","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2022.07.001_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11920-009-0080-3","article-title":"Sensitivity to antipsychotic drugs in older adults","volume":"12","author":"Leon","year":"2010","journal-title":"Curr Psychiatry Rep"},{"issue":"5","key":"10.1016\/j.psc.2022.07.001_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/11599460-000000000-00000","article-title":"Medication-related falls in the elderly: causative factors and preventive strategies","volume":"29","author":"Huang","year":"2012","journal-title":"Drugs Aging"},{"issue":"5","key":"10.1016\/j.psc.2022.07.001_bib39","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/schbul\/sbt043","article-title":"Treating older adults with schizophrenia: challenges and opportunities","volume":"39","author":"Jeste","year":"2013","journal-title":"Schizophr Bull"},{"issue":"4","key":"10.1016\/j.psc.2022.07.001_bib40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1017\/S1041610219000966","article-title":"An Australian study of delusional disorder in late life","volume":"32","author":"Nagendra","year":"2020","journal-title":"Int Psychogeriatr"},{"issue":"8","key":"10.1016\/j.psc.2022.07.001_bib41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/gps.4065","article-title":"Psychotic major depression in older people: a systematic review","volume":"29","author":"Gournellis","year":"2014","journal-title":"Int J Geriatr Psychiatry"},{"issue":"8","key":"10.1016\/j.psc.2022.07.001_bib42","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/archgenpsychiatry.2009.79","article-title":"A\u00a0double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD)","volume":"66","author":"Meyers","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"10.1016\/j.psc.2022.07.001_bib43","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jama.2019.10517","article-title":"Effect of continuing olanzapine vs placebo on relapse among patients with psychotic depression in remission: the stop-pd ii randomized clinical trial","volume":"322","author":"Flint","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.psc.2022.07.001_bib44","first-page":"1","article-title":"Expert consensus panel for pharmacotherapy of depressive disorders in older p. the expert consensus guideline series. pharmacotherapy of depressive disorders in older patients","volume":"Spec No Pharmacotherapy","author":"Alexopoulos","year":"2001","journal-title":"Postgrad Med"},{"issue":"2","key":"10.1016\/j.psc.2022.07.001_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.psc.2011.02.007","article-title":"Geriatric bipolar disorder","volume":"34","author":"Sajatovic","year":"2011","journal-title":"Psychiatr Clin North Am"},{"issue":"11","key":"10.1016\/j.psc.2022.07.001_bib46","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1176\/appi.ajp.2017.15050657","article-title":"GERI-BD: A randomized double-blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder","volume":"174","author":"Young","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2022.07.001_bib47","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.159.3.460","article-title":"Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients","volume":"159","author":"Pollock","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2022.07.001_bib48","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/JGP.0b013e3180cc1ff5","article-title":"A\u00a0double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia","volume":"15","author":"Pollock","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"issue":"7","key":"10.1016\/j.psc.2022.07.001_bib49","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.psc.2022.07.001_bib50","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.2016.15020248","article-title":"Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study","volume":"173","author":"Leonpacher","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2022.07.001_bib51","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jalz.2019.06.4946","article-title":"Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial","volume":"15","author":"Ehrhardt","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"15","key":"10.1016\/j.psc.2022.07.001_bib52","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease","volume":"355","author":"Schneider","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.psc.2022.07.001_bib53","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/appi.ajp.2008.07111779","article-title":"Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial","volume":"165","author":"Sultzer","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2022.07.001_bib54","doi-asserted-by":"crossref","first-page":"e190828","DOI":"10.1001\/jamanetworkopen.2019.0828","article-title":"Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia: a network meta-analysis","volume":"2","author":"Yunusa","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.psc.2022.07.001_bib55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa2034634","article-title":"Trial of pimavanserin in dementia-related psychosis","volume":"385","author":"Tariot","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.psc.2022.07.001_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jagp.2021.04.014","article-title":"Low dose lithium treatment of behavioral complications in alzheimer's disease: lit-ad randomized clinical trial","volume":"30","author":"Devanand","year":"2022","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2022.07.001_bib58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1533317509356692","article-title":"Off-label medication use in frontotemporal dementia","volume":"25","author":"Hu","year":"2010","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.psc.2022.07.001_bib59","first-page":"297","article-title":"Frontotemporal lobar degeneration: current perspectives","volume":"10","author":"Riedl","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"7","key":"10.1016\/j.psc.2022.07.001_bib60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11910-015-0567-8","article-title":"Psychotic symptoms in frontotemporal dementia","volume":"15","author":"Hall","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"12","key":"10.1016\/j.psc.2022.07.001_bib61","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/jnnp.2008.153163","article-title":"Impact of standard of care for psychosis in Parkinson disease","volume":"79","author":"Thomsen","year":"2008","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2022.07.001_bib62","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s40265-016-0600-5","article-title":"Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management","volume":"76","author":"Chang","year":"2016","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.psc.2022.07.001_bib63","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/14656566.2018.1445721","article-title":"Pharmacological interventions for psychosis in Parkinson's disease patients","volume":"19","author":"Friedman","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"10.1016\/j.psc.2022.07.001_bib64","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/gps.1764","article-title":"Antidepressants and psychosis in Parkinson disease: a case series","volume":"22","author":"Voon","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.psc.2022.07.001_bib65","first-page":"1","article-title":"Systematic review of pharmacological interventions for people with Lewy body dementia","author":"Watts","year":"2022","journal-title":"Aging Ment Health"},{"issue":"6855","key":"10.1016\/j.psc.2022.07.001_bib66","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bmj.305.6855.673","article-title":"Neuroleptic sensitivity in patients with senile dementia of Lewy body type","volume":"305","author":"McKeith","year":"1992","journal-title":"BMJ"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X22000570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X22000570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:41:52Z","timestamp":1759282912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X22000570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0193953X22000570"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2022.07.001","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychotic Disorders in the Elderly","name":"articletitle","label":"Article Title"},{"value":"Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psc.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}